These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10858115)

  • 1. [Proton therapy of uveal melanomas. Interview by H. Allouch].
    Desjardins L
    Presse Med; 2000 Apr 22-29; 29(15):842-4. PubMed ID: 10858115
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cyclotrons in cancerology: proton therapy used in uveal melanoma. Synthesis of clinical evaluation and guidelines].
    Allouch H
    Presse Med; 2000 Apr 22-29; 29(15):841-4. PubMed ID: 10827791
    [No Abstract]   [Full Text] [Related]  

  • 3. Regression rate of posterior uveal melanomas following iodine-125 plaque radiotherapy.
    Demirci H; Saponara F; Khan A; Niziol LM; Lee C; Hayman JA; Comer G; Musch DC
    Middle East Afr J Ophthalmol; 2015; 22(1):103-7. PubMed ID: 25624683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of uveal tract melanoma: A comprehensive review.
    Kapoor A; Beniwal V; Beniwal S; Mathur H; Kumar HS
    J Egypt Natl Canc Inst; 2016 Jun; 28(2):65-72. PubMed ID: 26975730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton beam therapy of uveal melanomas.
    Gragoudas ES
    Arch Ophthalmol; 1986 Mar; 104(3):349-51. PubMed ID: 3006647
    [No Abstract]   [Full Text] [Related]  

  • 6. [Report on 50 cases of uveal melanoma treated by conservative beta curietherapy].
    Grange JD; Bonnet M; Bievelez B; Jean-Louis B; Quintero P; Santamaria E; Guillaubey Y; Gérard JP; Delaroche G; Mere P
    Bull Soc Ophtalmol Fr; 1987 Nov; 87(11):1297-300. PubMed ID: 3451841
    [No Abstract]   [Full Text] [Related]  

  • 7. [Iodine-125 brachytherapy and trans-scleral tumor resection in large uveal melanomas].
    Bechrakis NE; Bornfeld N; Zöller I; Foerster MH
    Ophthalmologe; 2001 Aug; 98(8):736-42. PubMed ID: 11552413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid regression of a subset of class 1 uveal melanomas after Iodine-125 plaque radiotherapy suggests an inflammatory mechanism.
    Chen RW; Harbour JW
    Graefes Arch Clin Exp Ophthalmol; 2014 Dec; 252(12):2021-2. PubMed ID: 25212495
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic factors for metastasis following proton beam irradiation of uveal melanomas.
    Gragoudas ES; Seddon JM; Egan KM; Polivogianis L; Hsieh CC; Goitein M; Verhey L; Munzenrider J; Austin-Seymour M; Urie M
    Ophthalmology; 1986 May; 93(5):675-80. PubMed ID: 3014416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathologic findings in large uveal melanomas after brachytherapy with iodine 125 ophthalmic plaques.
    Schilling H; Bornfeld N; Friedrichs W; Pauleikhoff D; Sauerwein W; Wessing A
    Ger J Ophthalmol; 1994 Aug; 3(4-5):232-8. PubMed ID: 7804109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combined radiotherapy of uveal melanoma].
    Brovkina AF; Kesheleva VV; Fridman FE; Fishkin IG
    Vestn Oftalmol; 1997; 113(2):10-2. PubMed ID: 9229894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma. A prospective, randomized, dynamically balanced trial.
    Char DH; Quivey JM; Castro JR; Kroll S; Phillips T
    Ophthalmology; 1993 Oct; 100(10):1547-54. PubMed ID: 8414414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plaque radiotherapy for uveal melanoma.
    Shields JA; Shields CL; De Potter P; Cu-Unjieng A; Hernandez C; Brady LW
    Int Ophthalmol Clin; 1993; 33(3):129-35. PubMed ID: 8407177
    [No Abstract]   [Full Text] [Related]  

  • 14. Uveal melanoma: proton beam irradiation.
    Gragoudas ES; Marie Lane A
    Ophthalmol Clin North Am; 2005 Mar; 18(1):111-8, ix. PubMed ID: 15763196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of dose rate on clinical course in uveal melanoma after brachytherapy with ruthenium-106.
    Mossböck G; Rauscher T; Winkler P; Kapp KS; Langmann G
    Strahlenther Onkol; 2007 Oct; 183(10):571-5. PubMed ID: 17896089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton beam irradiation of uveal melanomas at Paul Scherrer Institute (former SIN).
    Zografos L; Perret C; Egger E; Gailloud C; Greiner R
    Strahlenther Onkol; 1990 Jan; 166(1):114. PubMed ID: 2154044
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical and technical requirements for proton treatment planning of ocular diseases. The SERAG (South Europe Radiotherapy Group).
    Chauvel P; Sauerwein W; Bornfeld N; Friedrichs W; Brassart N; Courdi A; Hérault J; Pignol JP; Bondiau PY; Malandain G
    Front Radiat Ther Oncol; 1997; 30():133-42. PubMed ID: 9205893
    [No Abstract]   [Full Text] [Related]  

  • 18. Irradiated uveal melanomas: cytopathologic correlation with prognosis.
    Char DH; Kroll SM; Miller T; Castro J; Quivey J
    Am J Ophthalmol; 1996 Oct; 122(4):509-13. PubMed ID: 8862047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton treatment of uveal melanomas.
    Bornfeld N
    Strahlenther Onkol; 2007 Jan; 183(1):1-2. PubMed ID: 17225938
    [No Abstract]   [Full Text] [Related]  

  • 20. Outcomes of iodine-125 plaque brachytherapy for uveal melanoma with intraoperative ultrasonography and supplemental transpupillary thermotherapy.
    Badiyan SN; Rao RC; Apicelli AJ; Acharya S; Verma V; Garsa AA; DeWees T; Speirs CK; Garcia-Ramirez J; Esthappan J; Grigsby PW; Harbour JW
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):801-5. PubMed ID: 24462385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.